// App-Quantinova.ai

5122 : Identification of PD-L1 expression on circulating tumor cells as a prognostic indicator in prospective clinical trial, OMNIVORE

Researchers

Presenter

  • Rory M. Bade

Principal Investigators

  • Jennifer L. Schehr

  • Matthew C. Mannino

  • Matthew L. Bootsma

  • Hamid Emamekhoo

  • Shuang G. Zhao

  • Toni K. Choueiri

  • Sabina Signoretti

  • Rana R. McKay

  • Joshua M. Lang

Medical Centers

  • Univ. of Wisconsin-Madison, Madison, WI.

  • Dana-Farber Cancer Institute, Boston, MA

  • University of California, San Diego, La Jolla, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

Biomarkers

  • Circulating tumor cells

  • Programmed death-ligand 1

  • Vascular endothelial growth factor A

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Ipilimumab

  • Nivolumab

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • NCT03203473

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved